leveraged buyout | GenomeWeb

leveraged buyout

NEW YORK (GenomeWeb News) – Citing a recent run up in Life Technologies' stock fueled by speculation that it may be positioning itself to be bought, investment bank Cowen & Co. today downgraded the Carlsbad, Calif.-based firm to Neutral from Outperform.

NEW YORK (GenomeWeb News) – Despite a report that a group of private equity firms were banding together to possibly acquire Life Technologies, shares of the Carlsbad, Calif.-based firm fell today.

NEW YORK (GenomeWeb News) – Shares of Life Technologies fell 7 percent in early Wednesday trade after a report from Reuters that potential acquirers for the firm have cooled

NEW YORK (GenomeWeb News) – Fitch Ratings today placed Life Technologies' ratings on Rating Watch Evolving following a report two weeks ago that the Carlsbad, Calif.-based firm may be looki

NEW YORK (GenomeWeb News) – Following a spike in Life Technologies' share price after a report that the company may be searching for a buyer, investment firm William Blair today downgra

NEW YORK (GenomeWeb News) – Shares of Life Technologies jumped 17 percent in Friday morning pre-market trading on reports that the firm may be seeking to sell itself.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.